NovoCure Ownership | Who Owns NovoCure?


OverviewForecastRevenueFinancialsChartTranscripts

NovoCure Ownership Summary


NovoCure is owned by 81.98% institutional investors, 9.86% insiders, and 8.15% retail investors. Fmr is the largest institutional shareholder, holding 15.03% of NVCR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 7.08% of its assets in NovoCure shares.

NVCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNovoCure81.98%9.86%8.15%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryMedical Instruments & Supplies Stocks40.77%13.85%45.38%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.77M15.03%$216.67M
Blackrock funding, inc. /de13.95M12.50%$180.20M
Blackrock12.13M11.31%$207.83M
Vanguard group10.46M9.37%$135.09M
Soleus capital management9.64M8.64%$124.61M
State street2.61M2.34%$33.73M
Geode capital management2.47M2.22%$31.98M
Balyasny asset management2.27M2.03%$40.41M
Capital world investors2.00M1.79%$25.84M
Nuveen1.71M1.53%$22.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Invus financial advisors350.88K6.74%$6.01M
Soleus capital management9.64M6.27%$124.61M
Palo alto investors lp1.26M3.00%$16.23M
Sio capital management413.83K1.35%$5.35M
Birchview capital, lp102.10K1.00%$1.32M
Bryce point capital48.98K0.77%$632.76K
Nordwand advisors256.63K0.53%$3.32M
Corton capital13.62K0.43%$175.93K
Washington capital management31.00K0.29%$400.52K
Hussman strategic advisors84.00K0.23%$1.09M

Top Buyers

HolderShares% AssetsChange
Blackrock12.13M0.00%3.05M
Soleus capital management9.64M6.27%2.74M
Nuveen1.71M0.01%681.40K
Balyasny asset management2.27M0.06%634.92K
Dimensional fund advisors lp565.76K0.00%539.61K

Top Sellers

HolderShares% AssetsChange
Capital investors---8.95M
Capital world investors2.00M0.00%-4.38M
Deerfield management company, l.p. (series c)---825.12K
Citigroup63.93K0.00%-641.71K
Coatue management---608.67K

New Positions

HolderShares% AssetsChangeValue
Schroder investment management group444.75K0.00%444.75K$5.75B
Sio capital management413.83K1.35%413.83K$5.35M
Vestal point capital, lp400.00K0.23%400.00K$5.17M
Axa investment managers371.77K0.01%371.77K$4.80M
Exoduspoint capital management, lp83.49K0.01%83.49K$1.08M

Sold Out

HolderChange
Northwestern mutual wealth management-1.00
Total investment management-1.00
Tfc financial management-3.00
Salem investment counselors-4.00
Pfg private wealth management-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252471.65%91,470,755-0.38%811.21%1313.15%748.82%
Jun 30, 20252474.22%94,464,090-0.79%841.14%12916.22%71-8.97%
Mar 31, 2025236-10.94%95,173,4933.94%861.21%110-14.06%782.63%
Dec 31, 20242495.51%88,494,339-4.72%811.11%11727.17%74-
Sep 30, 2024234-6.02%92,882,050-0.04%851.14%91-26.61%737.35%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S7.91M7.08%33.69K
Fidelity Growth Compy Commingled Pl O7.46M6.89%-
Fidelity Growth Company Fund5.44M4.86%-16.44K
American Funds SMALLCAP World A4.75M4.26%-3.59M
Vanguard US Total Market Shares ETF3.42M3.11%3.00K
Vanguard Total Stock Mkt Idx Inv3.37M3.01%-72.53K
American Funds Growth Fund of Amer A3.30M3.00%-5.51K
Capital Group Growth Fnd of Amer Comp3.30M2.96%-5.51K
Vanguard Small Cap Index2.57M2.30%-17.28K
iShares Russell 2000 ETF2.45M2.19%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 05, 2025Cordova Ashley Chief Executive OfficerBuy$996.86K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$116.30K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$58.00K
Jul 29, 2025Brackmann Christoph Chief Financial OfficerBuy$57.50K
Jun 03, 2025Stafford Kristin-Sell$17.26K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q34-
2025 Q2-12
2025 Q1-20
2024 Q4-4

NVCR Ownership FAQ


Who Owns NovoCure?

NovoCure shareholders are primarily institutional investors at 81.98%, followed by 9.86% insiders and 8.16% retail investors. The average institutional ownership in NovoCure's industry, Medical Instruments & Supplies Stocks, is 40.77%, which NovoCure exceeds.

Who owns the most shares of NovoCure?

NovoCure’s largest shareholders are Fmr (16.77M shares, 15.03%), Blackrock funding, inc. /de (13.95M shares, 12.50%), and Blackrock (12.13M shares, 11.31%). Together, they hold 38.84% of NovoCure’s total shares outstanding.

Does Blackrock own NovoCure?

Yes, BlackRock owns 11.31% of NovoCure, totaling 12.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 207.83M$. In the last quarter, BlackRock increased its holdings by 3.05M shares, a 33.55% change.

Who is NovoCure’s biggest shareholder by percentage of total assets invested?

Invus financial advisors is NovoCure’s biggest shareholder by percentage of total assets invested, with 6.74% of its assets in 350.88K NovoCure shares, valued at 6.01M$.

Who is the top mutual fund holder of NovoCure shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of NovoCure shares, with 7.08% of its total shares outstanding invested in 7.91M NovoCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools